The head of a review panel predicted the drug, Dsuvia, would cause more overdose deaths. But the F.D.A. said there were adequate safeguards. The New York Times By ABBY GOODNOUGH from NYT Health https://ift.tt/2AI1GrF November 1, 2018 at 02:00PM
No comments:
Post a Comment